KAKasra Azarnoush

Kasra Azarnoush

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Kasra Azarnoush has a total of 161 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • P‐TS‐38 | Impact of Amotosalen/UVA Treatment for Pathogen Reduction in Platelet Concentrates on Transfusion Efficacy in Cardiac Surgery

    by B. Bouali, A. Rezzaoui, H. Hamzeh‐Cognasse, A. Duchez, P. Chavarin, K. Azarnoush, J. Morel, J. Lanoiselée, J. Palao, F. Cognasse

  • Open Access

    Rapid-deployment aortic valve replacement in high-risk patients: A case-control study

    by Adama Sawadogo, An Vinh Bui-Duc, Nicolas D'OStrevy, Lionel Camilleri, Kasra Azarnoush

    Introduction: Aortic valve stenosis is the most frequent cardiac valve pathology in the western world. In high-risk patients, conventional aortic valve replacement (C-AVR) carries high rates of morbidity and mortality. In the last few years, rapid-deployment valves (RDV) have been developed to reduce the surgical risks. In this work, we aimed to compare the mid-term outcomes of rapid-deployment AVR (RD-AVR) with those of the C-AVR in high-risk patients. Methods: This retrospective case-control study identified 23 high-risk patients who underwent RD-AVR between 12/2015 to 01/2018. The study group was compared with a control group of 46 patients who were retrospectively selected from a database of 687 C-AVR patients from 2016 to 2017 which matched with the study group for age and Euro SCORE II. Results: RD-AVR group presented more cardiovascular risk factors. Euro SCORE II was higher in the RD-AVR group (P=0.06). In the RD-AVR group, we observed significantly higher mean prosthetic size (P<0.001). In-hospital mortality was zero in RD-AVR group versus 2 deaths in C-AVR group. Hospital stay was longer in the RD-AVR group with statistical significance (P=0.03). In the group AVR with associated cardiac procedures, while comparing subgroups RD-AVR versus C-AVR, early mean gradient was lower in the first cited (P=0.02). The overall mean follow-up was 10.9 ± 4.3 months. Conclusion: The RD-AVR technique is reliable and lead to positive outcomes. This procedure provides a much larger size with certainly better flow through the aortic root. It is an alternative to C-AVR in patients recognized to be surgically fragile.


  • Open Access

    Dietary EPA Increases Rat Mortality in Diabetes Mellitus, a Phenomenon Which Is Compensated by Green Tea Extract

    by Thibault Leger, Beibei He, Kasra Azarnoush, Chrystèle Jouve, Jean-Paul Rigaudiere, Florent Joffre, Damien Bouvier, Vincent Sapin, Bruno Pereira, Luc Demaison

    Diabetes is characterized by a high mortality rate which is often associated with heart failure. Green tea and eicosapentaenoic acid (EPA) are known to lessen some of the harmful impacts of diabetes and to exert cardio-protection. The aim of the study was to determine the effects of EPA, green tea extract (GTE), and a combination of both on the cardiac consequences of diabetes mellitus, induced in Wistar rats by injection of a low dose of streptozotocin (33 mg/kg) combined with a high fat diet. Cardiac mechanical function, coronary reactivity, and parameters of oxidative stress, inflammation, and energy metabolism were evaluated. In the context of diabetes, GTE alone limited several diabetes-related symptoms such as inflammation. It also slightly improved coronary reactivity and considerably enhanced lipid metabolism. EPA alone caused the rapid death of the animals, but this effect was negated by the addition of GTE in the diet. EPA and GTE combined enhanced coronary reactivity considerably more than GTE alone. In a context of significant oxidative stress such as during diabetes mellitus, EPA enrichment constitutes a risk factor for animal survival. It is essential to associate it with the antioxidants contained in GTE in order to decrease mortality rate and preserve cardiac function.


  • Cardiac Lymphoma Revealed by Atrial Mass

    by Adama Sawadogo, Bruno Miguel, Kasra Azarnoush, Lionel Camilleri

    Primary cardiac lymphoma (PCL) represents a very exceptional clinical entity whose treatment is based on chemotherapy. In this case report, the authors highlight the key role of cardiac surgery in the diagnosis of PCL in a 66-year-old female patient. She was given chemotherapy and so far was on remission.Cardiovasc. j. 2018; 11(1): 86-88

  • Inefficacy of Platelet Transfusion in a Heart Transplant Patient Under Continuous Ticagrelor

    by Laura Filaire, Dat T. Pham, Nicolas D’oStrevy, Huyen T. Tran, Lionel Camilleri, Kasra Azarnoush


  • Open Access

    Clinical outcomes of tricuspid valve repair accompanying left-sided heart disease

    by Kasra Azarnoush, Ahmad S Nadeemy, Bruno Pereira, Massoud A Leesar, Céline Lambert, Alaa Azhari, Vedat Eljezi, Nicolas Dauphin, Etienne Geoffroy, Lionel Camilleri

    Clinical outcomes of tricuspid valve repair accompanying left-sided heart disease


  • Are all heparins safe for on-pump heart surgery?

    by Kasra Azarnoush, Bruno Pereira, Aurelien Lebreton, Marie-Christine Zenut, Chouki Chenaf, Eljezi Vedat, Bernard Cosserant, Damien Bouvier, Nicolas D’ostrevy, Lionel Camilleri

    Background: Intravenous Panpharma heparin® was used in all on-pump cardiac surgery in our heart-surgery department for a short period. This brand of heparin replaced the previous Choay heparin® heparin supplied by the Sanofi-Aventis Laboratory. Unusual postoperative bleedings over this period prompted us to evaluate postoperative hemostasis by comparing these two heparins. Methods: We compared data from patients who had undergone on-pump cardiac surgery during Panpharma heparin® period (group P, 257 patients) to those how received Choay heparin® (group C, 194 patients). Results: Despite group P receiving a significantly lower dose of heparin (mean dose 21,000 IU/CEC) compared to group C (mean dose 22,000 IU/CEC) (p = 0.05), the number of surgical re-explorations needed to perfect postoperative hemostasis was significantly higher for group P (3.5% vs. 0) (p = 0.01). Heparin anti-Xa activity after surgery was higher in group P at postoperative h1 and h12 compared to group C, which explained reoperations for hemostasis. Conclusion: Despite standardization, variations remain regarding anticoagulant activity between different manufacturing processes and heparin preparations. Surgical teams need to be aware that the biological effects of different brands of heparin may not be as expected and could endanger a usually safe procedure, such as cardiac surgery.


  • Impact des techniques interventionnelles dans le traitement de la valvulopathie aortique après revascularisation myocardique chirurgicale préalable

    by W. Gandji, K. Azarnoush, A. Mulliez, A. Innorta, M. Farhat, N. Combaret, N. Durel, G. Souteyrand, J.R. Lusson, L. Camilleri

  • Long-term abdominal adiposity activates several parameters of cardiac energy function

    by Evangelia Mourmoura, Jean-Paul Rigaudière, Karine Couturier, Isabelle Hininger, Brigitte Laillet, Corinne Malpuech-Brugère, Kasra Azarnoush, Luc Demaison

    Abdominal obesity increases the incidence of cardiac events but reduces mortality when one of these events occurs. The phenomenon called obesity paradox might be related to myocardial energetics. This study was aimed at determining whether long-term abdominal adiposity alters cardiac energy function. Two groups of male Wistar rats were fed a standard or a Western-type (WD) diet for 8 months. The ex vivo coronary reactivity and mechanical function as well as the mitochondrial oxidative phosphorylation (mOxPhos) and hydrogen peroxide release (mH2O2r) were determined. Abdominal adiposity was augmented by the WD. This was also the case for the coronary reactivity to acetylcholine, but the rate pressure product remained roughly stable despite a reduction of the left ventricle-developed pressure partly compensated by a slight increase in heart rate. The prolonged WD administration resulted in an improvement of mOxPhos, but the mH2O2r was exaggerated which was confirmed in the whole cell by a reduced aconitase to fumarase ratio. This did not modify the plasma oxidative stress due to an increased plasma antioxidant status. In conclusion, long-term WD administration improved the cardiac fitness and might predispose the organism to the obesity paradox. Conversely, the increased mitochondrial mH2O2r can precipitate the heart toward cardiomyopathy if the WD is maintained for a longer duration.


  • Open Access

    Severe non-traumatic bleeding events detected by computed tomography: do anticoagulants and antiplatelet agents have a role?

    by Olivier Risch, Agaicha Alfidja, Aurelien Mulliez, Anderson H Amani, Louis Boyer, Lionel Camilleri, Kasra Azarnoush

    Bleeding is the most common and most serious complication of anticoagulant (AC) and antiplatelet agents (APA) which are increasingly used in every day practice. The aim of this study was to enlist and analyze the most severe bleeding events revealed during computed tomography scanner (CT scan) examinations over a 1-year period at our University Hospital and to evaluate the role of ACs and APAs in their occurrence. This descriptive monocentric retrospective study included all patients who benefited from an emergency CT scan with a diagnosis of severe non-traumatic bleeding. Patients were divided into two groups: those treated with ACs and/or APAs, and those not treated with ACs or APAs. After applying the inclusion criteria, 93 patients were enrolled. Sixty-one patients received an anticoagulant or antiplatelet treatment, and 32 did not receive any AC or APA therapy. Seventy nine percent presented with an intracranial hemorrhage, 17% with a rectus sheath or iliopsoas bleeding or hematoma, and 4% with a quadriceps hematoma. Only patients who received ACs or APAs suffered a muscular hematoma (p 3). In our series, intracranial hemorrhage was preponderant and muscular hematomas occurred exclusively in patients treated with ACs and/or APAs. This study needs to be extended to evaluate the impact of new anticoagulant and antiplatelet agents.